GSK: Summary for GLAXOSMITHKLINE PLC - Yahoo! Canada Finance

	Sign In [New User? Sign Up]	Finance Home \|Help

Wednesday, February 10, 2010, 4:39am EST - Canadian Markets open in 4 hours and 51 minutes.

To create a watchlist or portfolio of shares, Sign-in or Register

GlaxoSmithKline plc (GSK)

On Feb 9: 38.47 USD 0.00 (0.00%)

MORE ON GSK

Quotes

Summary

Charts

News & Info

Company

Analyst Coverage

Ownership

Financials

GLAXOSMITHKLINE PLC (NYSE:GSK) Delayed quote data

Last Trade:	38.47 USD
Trade Time:	Feb 9
Change:	0.00 (0.00%)
Prev Close:	37.89
Open:	N/A
Bid:	N/A
Ask:	N/A
1y Target Est:	42.00

Day's Range:	N/A - N/A
52wk Range:	27.15 - 43.47
Volume:	0
Avg Vol (3m):	1,788,550
Market Cap:	97.52B
P/E (ttm):	12.91
EPS (ttm):	2.98
Div & Yield:	1.86 (4.90%)

1d 5d 3m 6m 1y 2y 5y max

Free Annual Reports

Add GSK to Portfolio

Download Data

HEADLINES

•	Bone Up On This Potential Blockbuster
	at Motley Fool (Tue 11:58am)

•	Europe Launches Probe into Pharma Deals
	at BusinessWeek (Tue 10:52am)

•	Germany Cancels Swine Flu Vaccines
	at BusinessWeek (Tue 10:52am)

•	Glaxo considering job cuts at UK research center
	AP (Tue 10:41am)

•	Biotech Deal-Making Crosses Borders as Capital Markets Slide
	at Seeking Alpha (Tue 4:32am)

•	Dynavax starts hepatitis B trial
	at bizjournals.com (Mon, Feb 8)

•	Popular antidepressant interferes with cancer drug
	at Reuters (Mon, Feb 8)

•	UPDATE - Roche licenses new flu-fighting technology
	at Reuters (Mon, Feb 8)

•	GlaxoSmithKline, Poniard, Protalix Provide Biotech's Latest Mishaps
	at Seeking Alpha (Mon, Feb 8)

•	How Big Pharma Got in This Fix
	at Seeking Alpha (Sun, Feb 7)

•	Believe In The Market's Healthy Skepticism
	at Forbes.com (Fri, Feb 5)

•	Big Pharma's Shot In The Arm
	at CNBC (Fri, Feb 5)

•	Vaccines Drive Glaxo's Revenues
	Zacks.com (Fri, Feb 5)

•	Business Highlights
	AP (Thu, Feb 4)

More Headlines for GSK...

ANALYST

EPS Est (next year) (Dec-09) :	3.82
EPS Est (in 2 years) (Dec-10) :	3.98
Avg Rec (current)*:	3.3
PEG Ratio:	2.29

* (Strong Buy) 1.0 - 5.0 (Strong Sell)

Analyst Opinion - Estimates

BUSINESS SUMMARY

GlaxoSmithKline plc, together with its subsidiaries, engages in the creation, discovery, development, manufacture, and marketing of pharmaceutical products, over the counter (OTC) medicines, and health related consumer products.

Full Company Profile

Add to Portfolio

Email to a Friend

•